Effect of ganglion blockade with pentolinium on circulating neuropeptide Y levels in conscious rats.
The vasoconstrictor peptide, neuropeptide Y (NPY), is present in perivascular noradrenergic neurons of all mammals studied and may be important in the regulation of blood pressure. High plasma levels of NPY have been measured in the rat. To investigate partially the source and factors controlling the release of the circulating peptide, the effect of pentolinium tartrate administration has been studied in conscious rats. Pentolinium given as a bolus (5 mg/kg) followed by an infusion of a further 5 mg/kg/30 min produced a highly significant reduction in blood pressure of more than 40 mm Hg, when compared to either basal values or control animals treated with saline. Pentolinium treatment resulted in significantly lower plasma neuropeptide Y levels (31.0 +/- 6.7 fmol/ml) compared with those of control animals (78.6 +/- 8.2 fmol/ml). Circulating catecholamines were also significantly reduced in those animals receiving pentolinium. These results are compatible with circulating NPY arising from the sympathetic nervous system, with release being controlled by the mechanisms already established for catecholamines.
Corder
R
R
Department of Medicine, University Hospital, Geneva, Switzerland.
Waeber
B
B
Evequoz
D
D
Nussberger
J
J
Gaillard
R
R
Brunner
H
H
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D005730:Ganglionic Blockers / Q000494:pharmacology*; D006339:Heart Rate / Q000187:drug effects; D008297:Male; D009478:Neuropeptide Y / Q000097:blood*; D010425:Pentolinium Tartrate / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains
D005730:Ganglionic Blockers; D009478:Neuropeptide Y; D010425:Pentolinium Tartrate